FreeTrader
عضو محترف
Gapping Up
GNVC +45% (Announces New $52 Million Contract with NIH/NIAID Vaccine Research Center to Support HIV Vaccine Production)... CRIS +24.4% (announces Genentech filing of Investigational New Drug application for systemic administration of a hedgehog antagonist)... TRMS +10.8% (data from HIV study)... MTRX +7.9% (announces the appointment of Michael Bradley as President and CEO)... TASR +5.8% (receives several orders for Taser X26 devices, sees Q3 revs of approx $18 mln)... ASCA +4.5% (increases Q3 gudiance)... SIMG +4.1% (initiated with a Buy at AmTech)... TJX +3.2% (reports comps, raises guidance)... CAI +2.4% (wins $1.9 bln contract)... OSUR +2.4% (announces promotions of Ronald Spair to COO)... HBC +2.3% (WSJ story)... LTD +1.5% (comp store sales)... CHS +1.2% (comp store sales)... WYE +1.2% (raises Y06 EPS guidance)... AEOS +1.0% (reports Sep comps).
GNVC +45% (Announces New $52 Million Contract with NIH/NIAID Vaccine Research Center to Support HIV Vaccine Production)... CRIS +24.4% (announces Genentech filing of Investigational New Drug application for systemic administration of a hedgehog antagonist)... TRMS +10.8% (data from HIV study)... MTRX +7.9% (announces the appointment of Michael Bradley as President and CEO)... TASR +5.8% (receives several orders for Taser X26 devices, sees Q3 revs of approx $18 mln)... ASCA +4.5% (increases Q3 gudiance)... SIMG +4.1% (initiated with a Buy at AmTech)... TJX +3.2% (reports comps, raises guidance)... CAI +2.4% (wins $1.9 bln contract)... OSUR +2.4% (announces promotions of Ronald Spair to COO)... HBC +2.3% (WSJ story)... LTD +1.5% (comp store sales)... CHS +1.2% (comp store sales)... WYE +1.2% (raises Y06 EPS guidance)... AEOS +1.0% (reports Sep comps).